About 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may ...

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

This link between central fat and ... Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment ...

Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...

Key Takeaways Belly flab is a powerful warning sign for psoriasisAbdominal fat is tied to psoriasis risk much more strongly than fat located elsewhere on the bodyThe association is much stronger in ...

Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.

These ingredients are ideal for inflammatory skin conditions like eczema and psoriasis because they can help relieve itchiness, dryness and scaling on the skin. To strengthen your skin barrier ...

which enrolled adults and adolescents 12 years of age and older with moderate to severe plaque psoriasis. Top-line results show that 64.7% of patients achieved clear or almost clear skin measured ...

Taking care of your skin is vital when you live with psoriasis. Before getting a tattoo or applying a new lotion, it's important to know the risks and what to avoid.

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

Most patients with psoriasis experienced clinical improvement or remission after metabolic and bariatric surgery (MBS) in a ...